Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-321797.64%
↓ 3888% vs avg
Percentile
P0
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
-8068.33%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -321797.64% |
| Q3 2025 | 2.15% |
| Q2 2025 | -212.77% |
| Q1 2025 | 56.52% |
| Q4 2024 | -27.09% |
| Q3 2024 | 5.26% |
| Q2 2024 | -868.79% |
| Q1 2024 | 89.06% |
| Q4 2023 | -31.83% |
| Q3 2023 | 6.61% |
| Q2 2023 | -323.69% |
| Q1 2023 | 161.00% |
| Q4 2022 | -21.40% |
| Q3 2022 | 13.09% |
| Q2 2022 | -127.21% |
| Q1 2022 | 527.30% |
| Q4 2021 | -68.60% |
| Q3 2021 | 26.06% |
| Q2 2021 | -35.59% |
| Q1 2021 | 13.35% |
| Q4 2020 | -29.04% |
| Q3 2020 | -47.65% |
| Q2 2020 | -65.55% |
| Q1 2020 | 31.76% |
| Q4 2019 | -8.09% |
| Q3 2019 | 7.09% |
| Q2 2019 | -10.56% |
| Q1 2019 | 57.37% |
| Q4 2018 | -26.47% |
| Q3 2018 | 19.22% |
| Q2 2018 | -8.01% |
| Q1 2018 | -28.14% |
| Q4 2017 | 16.38% |
| Q3 2017 | 13.75% |
| Q2 2017 | 20.91% |
| Q1 2017 | -10.72% |
| Q4 2016 | -68.00% |
| Q3 2016 | 48.53% |
| Q2 2016 | -16.80% |
| Q1 2016 | -14.79% |